ATE410427T1 - Neues kristallines tricyclisches triazolobenzazepinderivat - Google Patents

Neues kristallines tricyclisches triazolobenzazepinderivat

Info

Publication number
ATE410427T1
ATE410427T1 AT02790870T AT02790870T ATE410427T1 AT E410427 T1 ATE410427 T1 AT E410427T1 AT 02790870 T AT02790870 T AT 02790870T AT 02790870 T AT02790870 T AT 02790870T AT E410427 T1 ATE410427 T1 AT E410427T1
Authority
AT
Austria
Prior art keywords
new crystalline
derivative
tricyclic triazolobenzazepine
triazolobenzazepine derivative
crystalline tricyclic
Prior art date
Application number
AT02790870T
Other languages
English (en)
Inventor
S Kitahara
Hanae Furukawa
Toshihiro Yamaguchi
S Miyamoto
Yumiko Okada
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE410427T1 publication Critical patent/ATE410427T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02790870T 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat ATE410427T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001393016 2001-12-26

Publications (1)

Publication Number Publication Date
ATE410427T1 true ATE410427T1 (de) 2008-10-15

Family

ID=19188739

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02790871T ATE469902T1 (de) 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats
AT02790870T ATE410427T1 (de) 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02790871T ATE469902T1 (de) 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats

Country Status (11)

Country Link
US (2) US7229985B2 (de)
EP (2) EP1469000B1 (de)
JP (2) JP4376628B2 (de)
KR (1) KR100848724B1 (de)
CN (1) CN1275968C (de)
AT (2) ATE469902T1 (de)
AU (2) AU2002367109A1 (de)
CA (1) CA2471651C (de)
DE (2) DE60229298D1 (de)
ES (2) ES2346858T3 (de)
WO (2) WO2003055886A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113343A1 (ja) * 2003-06-19 2004-12-29 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
EP1650266A1 (de) * 2003-06-20 2006-04-26 Meiji Seika Kaisha Ltd. Produkt der copräzipitation einer schlecht löslichen substanz und eines wasserlöslichen polymers und herstellungsverfahren dafür
US7910575B2 (en) * 2006-03-02 2011-03-22 Meiji Seika Kaisha, Ltd. Prophylactic or therapeutic agents for allergic ophthalmic diseases or allergic nasal diseases, comprising tricyclic triazolobenzazepine derivative
TW200843903A (en) * 2007-05-03 2008-11-16 Univ Nat Central Abrasives with function of sliding grinding and its manufacturing method
PT2123277E (pt) * 2007-12-18 2011-04-20 Meiji Seika Kaisha Agente preventivo ou terapêutico para doenças inflamatórias do intestino
EP2263671B1 (de) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amidderivathaltige pharmazeutische zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888350A1 (de) 1996-03-08 1999-01-07 Zeneca Limited Azolobenzazepinderivate als neurologisch aktive mittel
US6574603B1 (en) * 1997-09-26 2003-06-03 Gilbarco Inc. In-vehicle ordering
ES2191963T3 (es) * 1997-09-29 2003-09-16 Meiji Seika Kaisha Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.

Also Published As

Publication number Publication date
DE60236623D1 (de) 2010-07-15
WO2003055885A1 (en) 2003-07-10
DE60229298D1 (de) 2008-11-20
EP1466914A1 (de) 2004-10-13
KR100848724B1 (ko) 2008-07-25
JP4376628B2 (ja) 2009-12-02
JPWO2003055886A1 (ja) 2005-09-02
EP1469000A1 (de) 2004-10-20
EP1466914A4 (de) 2005-12-07
EP1469000B1 (de) 2008-10-08
US20050020579A1 (en) 2005-01-27
AU2002367109A1 (en) 2003-07-15
CA2471651C (en) 2010-01-26
CA2471651A1 (en) 2003-07-10
EP1466914B1 (de) 2010-06-02
KR20040072682A (ko) 2004-08-18
ES2346858T3 (es) 2010-10-21
ES2312650T3 (es) 2009-03-01
JPWO2003055885A1 (ja) 2005-05-12
US7229985B2 (en) 2007-06-12
EP1469000A4 (de) 2005-12-07
WO2003055886A1 (en) 2003-07-10
CN1617872A (zh) 2005-05-18
US20050130955A1 (en) 2005-06-16
AU2002367110A1 (en) 2003-07-15
ATE469902T1 (de) 2010-06-15
US7002009B2 (en) 2006-02-21
CN1275968C (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
MA26937A1 (fr) Nouvelle composition pharmaceutique.
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
IT1308627B1 (it) Composizioni fluoroelastomeriche.
IT1308628B1 (it) Composizioni fluoroelastomeriche.
DE69922267D1 (de) Bewegliches zusammensetzspiel
DE60135387D1 (de) 7,9 substituierte tetracyclinverbindungen
ATE295081T1 (de) Hilfsstoff-zusammensetzung
DE60010601D1 (de) Vernetzbare Fluorelastomerzusammensetzungen
MXPA03006991A (es) Derivados de piperidina como antagonistas de neurocinina 1.
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
NL1016364A1 (nl) Vuurvaste thermoplastische harssamenstelling.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE60020341D1 (de) Kerzenzusammensetzung
DE60229298D1 (de) Neues kristallines tricyclisches triazolobenzazepinderivat
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
DE50208676D1 (de) Builder-Zusammensetzung
ITTO20020744A1 (it) Composizione.
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
ZA200110500B (en) Pharmaceutical composition.
AU4859301A (en) Antihistaminic compounds
ITTO20020745A1 (it) Composizione.
MXPA03007318A (es) Composicion farmaceutica.
DK1497256T3 (da) Substituerede 1,5-diaminopentan-3-ol-forbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties